Photocure ASA
OSE:PHO
Photocure ASA
Total Assets
Photocure ASA
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Photocure ASA
OSE:PHO
|
Total Assets
kr733.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
|
V
|
Vistin Pharma ASA
OSE:VISTN
|
Total Assets
kr384.9m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
N
|
Navamedic ASA
OSE:NAVA
|
Total Assets
kr491.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
21%
|
CAGR 10-Years
8%
|
|
|
S
|
SoftOx Solutions AS
OSE:SOFTX
|
Total Assets
kr103.4m
|
CAGR 3-Years
18%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Photocure ASA
Glance View
Photocure ASA delivers transformative solutions to improve the lives of bladder cancer patients. The company is headquartered in Oslo, Oslo. The company went IPO on 2000-05-29. The company operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection and management of bladder cancer; Visonac, for acne treatment; Cevira, used in HPV and precancerous lesions of the cervix treatment; and Lumacan, applied in colorectal cancer treatment. Furthermore, It owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. The firm is a parent of a wholly owned entity, Photocure Inc.
See Also
What is Photocure ASA's Total Assets?
Total Assets
733.4m
NOK
Based on the financial report for Dec 31, 2024, Photocure ASA's Total Assets amounts to 733.4m NOK.
What is Photocure ASA's Total Assets growth rate?
Total Assets CAGR 10Y
10%
Over the last year, the Total Assets growth was 3%. The average annual Total Assets growth rates for Photocure ASA have been -2% over the past three years , 23% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet